Oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer patients

Oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer patients

ObjectiveThis study aimed to discuss the influence of oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer (CRC) patients.MethodsA total of 100 advanced CRC patients, selected from January 2019 to January 2021, were divided into a control group (CG)...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dan Kuang, Hong Xu, Xiaoming Shen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Medicine
Subjects:	colorectal cancer oxaliplatin capecitabine chemotherapy comprehensive nursing
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1582683/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patients
by: E. El Rawadi, et al.
Published: (2025-06-01)

Salinomycin and oxaliplatin synergistically enhances cytotoxic effect on human colorectal cancer cells in vitro and in vivo
by: Fang Liu, et al.
Published: (2025-04-01)

A placebo-controlled study of the doses and efficacy of Lentinula edodes mycelia for oxaliplatin-induced peripheral neuropathy in colorectal cancer
by: Shogen Boku, et al.
Published: (2025-08-01)

Clinical pharmacokinetics of capecitabine and its metabolites in colorectal cancer patients
by: Saeed Alqahtani, et al.
Published: (2022-05-01)

Effect of Melatonin on Oxaliplatin Induced Neuropathy in Patients Receiving Folfox Chemotherapy Regimens for Stage II–IV Colorectal Cancer: A Randomized, Placebo Controlled, Double Blind Trial
by: Raziyeh Kheshti, et al.
Published: (2025-05-01)

Predictive value of serum miR-21 and miR-122 expression on the efficacy of capecitabine combined with transcatheter hepatic arterial embolization chemotherapy for liver metastasis after colorectal cancer surgery in patients with colorectal cancer and construction and verification of nomograms
by: Wenfang Ma, et al.
Published: (2025-07-01)

Exosomes and their distinct integrins transfer the characteristics of oxaliplatin- and 5-FU-resistant behaviors in colorectal cancer cells
by: Zeynab Vakili-Ghartavol, et al.
Published: (2025-02-01)

Response of Capecitabine and Oxaliplatin Chemotherapy in Metastatic Colorectal Carcinoma
by: Asma Abdul Rashid, et al.
Published: (2025-01-01)

Incidence of myocardial ischemia during treatment with capecitabine: a cohort study with Holter recording and cardiac biomarkers
by: Anne Dyhl-Polk, et al.
Published: (2025-07-01)

Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer
by: Frankie Ann Holmes, et al.
Published: (2018-06-01)

Cetuximab-Taxanes-Platinum-Fluorouracil/Capecitabine (C-TPF/C-TPX) – a Feasible Option for Recurrent HNSCC with Negative Prognostic Factors. Literature Review with a Case Presentation
by: Camil Ciprian MIRESTEAN, et al.
Published: (2023-03-01)

COVID-19 lockdown-related treatment modifications did not impact the outcome of digestive cancers: the Clin-COVIDICA prospective study
by: Violaine Randrian, et al.
Published: (2025-03-01)

Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)
by: Jieun Lee, et al.
Published: (2025-08-01)

Independent risk and protective factors for oxaliplatin-induced hypersensitivity reactions: a retrospective study
by: Jing Xue, et al.
Published: (2025-07-01)

Case Report: Cardiotoxicity of capecitabine may manifest as STEMI with significant left ventricular cardiac dysfunction and recurrent supraventricular and ventricular arrhythmias: a proposal for optimal diagnosis and treatment
by: Sebastian Szmit, et al.
Published: (2025-06-01)

IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER
by: E. M. Slonimskaya, et al.
Published: (2016-07-01)

Oxaliplatin-induced lung fibrosis
by: Shah Arpan, et al.
Published: (2009-01-01)

Investigating the cytotoxic effect of aqueous extract of Peganum harmala on oxaliplatin-resistant HCT116 cell line and evaluating BAX gene expression
by: Zahra Salimizadeh, et al.
Published: (2025-03-01)

CAPECITABINE IN THE TREATMENT OF BRAIN METASTATIC LESION IN PATIENTS WITH BREAST CANCER
by: E. A. Moskvina, et al.
Published: (2015-04-01)

Syndrome of inappropriate antidiuretic hormone secretion in a patient with colon cancer using CAPOX plus bevacizumab therapy: a case report
by: Masanobu Uchiyama, et al.
Published: (2025-07-01)

A pathological complete response by chemotherapy with S-1 and oxaliplatin for a locally advanced duodenal adenocarcinoma in Lynch syndrome: a case report
by: Satoshi Yasuda, et al.
Published: (2019-10-01)

THBS2 + cancer-associated fibroblasts promote EMT leading to oxaliplatin resistance via COL8A1-mediated PI3K/AKT activation in colorectal cancer
by: Xing Zhou, et al.
Published: (2024-12-01)

Therapeutic effect of Chelidonium majus hydro-alcoholic extract alone and in combination with oxaliplatin on ovarian cancer cell line
by: Zahra Hashempour, et al.
Published: (2025-07-01)

DETERMINATION OF CAPECITABINE AND ITS ACTIVE METABOLITE 5-FLUOROURACIL IN BLOOD PLASMA BY HPLC-MS/MS
by: E. S. Melnikov, et al.
Published: (2019-01-01)

Dupilumab for management of capecitabine-induced hand-foot syndrome
by: Ian Nykaza, BS, et al.
Published: (2025-09-01)

Drug-Induced Liver Injury and the Likelihood of Hepatocellular Carcinoma During Chemotherapy for Colorectal Cancer (Meta-Analysis)
by: T. N. Garmanova, et al.
Published: (2025-08-01)

Influence of Citrobacter freundii on NINJ2 Expression and Oxaliplatin Resistance in Colorectal Cancer
by: Reio Ueta, et al.
Published: (2025-07-01)

Development of an Early-Warning Model for Predicting the Capecitabine-Induced Diarrhea
by: Liu Z, et al.
Published: (2025-06-01)

ACUTE MYOCARDIAL INFARCTION IN THE ABSENCE OF CORONARY ARTERY OBSTRUCTION – A COMPLICATION OF ANTICANCER THERAPY WITH CAPECITABINE
by: E. A. Kolomiets, et al.
Published: (2017-12-01)

Overexpression of Protein Kinase C iota as a prognostic marker and its role in oxaliplatin resistance in colorectal cancer
by: Xuankai Liao, et al.
Published: (2025-08-01)

Phosphorylation of KIAA1429 promotes oxaliplatin resistance through activating the FZD7-Wnt signaling in BRAFV600E-mutated colorectal cancer
by: Taixuan Wan, et al.
Published: (2025-07-01)

Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer
by: Meiling Gao, et al.
Published: (2025-07-01)

Comparative study of low dose of capecitabine versus standard dose in metastatic breast cancer: Efficacy and safety
by: Aboelnaga Engy M, et al.
Published: (2021-08-01)

A phase I/II trial evaluating the safety of increased-dose S- 1 with oxaliplatin and nivolumab in HER2-negative advanced gastric cancer
by: Keisuke Baba, et al.
Published: (2025-04-01)

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
by: Akira Dejima, et al.
Published: (2023-11-01)

Adjuvant Gemcitabine-cisplatin Combination for Biliary Tract Cancer: A Real Life Experience
by: Fatih Kuş, et al.
Published: (2025-08-01)

A Case Report Capecitabine-Induce Grade II Hand and Foot Syndrome
by: Nurul Damayanti, et al.
Published: (2025-07-01)

Oxygen vacancy-engineered bimetallic nanozymes for disrupting electron transport chain and synergistic multi-enzyme activity to reverse oxaliplatin resistance in colorectal cancer
by: Dong Zhong, et al.
Published: (2025-05-01)

Short-term and long-term oncological outcomes of chemoradiotherapy for rectal cancer patients with or without oxaliplatin: a propensity score-matched retrospective analysis
by: Amirali Azimi, et al.
Published: (2024-12-01)

Successful conservative management of massive oxaliplatin extravasation from a central venous port with early systemic corticosteroid therapy
by: Shunsuke Takahagi, et al.
Published: (2025-07-01)